Member Bibliography/Bibliografía de Miembros
This page collects all the personal publications that CienciaPR members have uploaded to their profiles. You can also see all of the authors collected in these publications or all the keywords contained in these publications.
“Serial cervicovaginal exposures with replication-deficient SIVsm induce higher dendritic cell (pDC) and CD4+ T-cell infiltrates not associated with prevention but a more severe SIVmac251 infection of rhesus macaques.”, J Acquir Immune Defic Syndr, vol. 65, no. 4, pp. 405-13, 2014.
, “Improved treatment for primary HIV infection by interferon-alfa therapy? Does HCV treatment in HIV/HCV coinfected patients help us to test this hypothesis? Reply to zur Wiesch and van Lunzen.”, J Infect Dis, vol. 208, no. 2, p. 363, 2013.
“Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration.”, J Infect Dis, vol. 207, no. 2, pp. 213-22, 2013.
“Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals.”, AIDS, vol. 26, no. 11, pp. 1355-62, 2012.
“Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials.”, AIDS, vol. 26, no. 18, pp. 2295-306, 2012.
“Prioritizing CD4 count monitoring in response to ART in resource-constrained settings: a retrospective application of prediction-based classification.”, PLoS Med, vol. 9, no. 4, p. e1001207, 2012.
“Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational study.”, J Int AIDS Soc, vol. 14, p. 37, 2011.
“Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection.”, J Acquir Immune Defic Syndr, vol. 58, no. 3, pp. 309-18, 2011.
“Randomized trial of time-limited interruptions of protease inhibitor-based antiretroviral therapy (ART) vs. continuous therapy for HIV-1 infection.”, PLoS One, vol. 6, no. 6, p. e21450, 2011.
“Association between HIV replication and serum leptin levels: an observational study of a cohort of HIV-1-infected South African women.”, J Int AIDS Soc, vol. 13, p. 33, 2010.
“Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus- and host-mediated apoptosis resistance.”, J Immunol, vol. 182, no. 7, pp. 4459-70, 2009.
“Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in HIV-1-infected subjects undergoing antiretroviral treatment.”, J Immunol, vol. 179, no. 4, pp. 2642-50, 2007.
“Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells.”, AIDS, vol. 21, no. 3, pp. 293-305, 2007.